Send to

Choose Destination
Rev Alerg Mex. 2019 Apr-Jun;66(2):192-204. doi: 10.29262/ram.v66i2.591.

[Epidemiological study on atopic dermatitis in Mexico].

[Article in Spanish; Abstract available in Spanish from the publisher]

Author information

Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Ciudad de México, México.


in English, Spanish


There is limited epidemiological information on the treatment of atopic dermatitis (AD) from specialist physicians in Mexico.


To know the criteria that is used by specialists in Mexico to diagnose and treat AD.


An observational, descriptive and cross-sectional study, which was authorized by the ethics committee, was carried out through an electronic survey.


114 surveys were carried out; 56% of the participants were allergists, 38% were dermatologists and 5% were pediatricians. It was identified that 54% used clinical criteria for the diagnosis of AD and 42% used the criteria of Hanifin-Rajka as a diagnostic complement; 38% requested total and/or specific IgE, blood biometry and blood chemistry tests. They recount that 90% of patients under the age of 18 had mild AD, 8% had moderate AD and 2% had severe AD; and, in patients over the age of 18, 89% had mild AD, 6% had moderate AD and 5% had severe AD. The patients' care was multidisciplinary, since 57% of the survey respondents requested assessments combined with ophthalmology, dermatology and allergology.


Knowledge of the disease will lead to a better control of the disease. The challenge is to have a patient registry, update treatment guidelines, consider comorbidities and have therapeutic options for its control.


Atopic dermatitis; Eczematous skin diseases; Epidemiology


Supplemental Content

Loading ...
Support Center